• Home
  • KU, Harvard researchers team up to look for Alzheimer’s treatment clues

KU, Harvard researchers team up to look for Alzheimer’s treatment clues

Wednesday, December 5, 2012

Chris Gamblin, associate professor of molecular biosciences at the University of Kansas, and a pathologist at Harvard Medical School have teamed up -- with the help of a $1.7 million National Institutes of Health grant -- to combine their research on Alzheimer's.

Their project focuses on the tau protien, one of two main proteins associated with Alzheimer's. Many questions surround tau, and the answers to those questions could lead to a completely new form of treatment for the disease.

Read the Lawrence Journal World article on the researcher's collaboration and the implications of their project.